Melinta Therapeutics Inc. buy stratec
Start price
29.10.18
/
50%
€11.50
Target price
23.12.19
€31.57
Performance (%)
-88.70%
End price
23.12.19
€1.30
Summary
This prediction ended on 23.12.19 with a price of €1.30. The BUY prediction by stratec for Melinta Therapeutics Inc. performed very badly with a performance of -88.70%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Melinta Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by stratec for this prediction
In the thread Melinta Therapeutics Inc. diskutieren
stratec stimmt der Buy-Einschätzung von Quitte zu
stratec stimmt am 29.10.2018 der Buy-Einschätzung von Quitte mit dem Kursziel 7$ zu.
Überschrift: die kommt